Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke
Status: | Completed |
---|---|
Conditions: | Smoking Cessation, Smoking Cessation, Smoking Cessation, Tobacco Consumers |
Therapuetic Areas: | Pulmonary / Respiratory Diseases |
Healthy: | No |
Age Range: | 23 - 72 |
Updated: | 4/21/2016 |
Start Date: | September 2011 |
End Date: | December 2011 |
A Single Center, Single-Blind, Randomized, Crossover Pilot Study to Evaluate the Safety and Effects of Anatablocâ„¢, a Dietary Supplement, in Reducing the Urge to Smoke in Daily Smokers Followed by an Open-Label Extension
This study will consist of 2 phases. Phase 1 will be a one day crossover study to see the
effects of study product on a smoker's desire to smoke, measured by changes in scores on
questionnaires given over time. Phase 2 will be a two-week extension, in which subjects will
self-administer the study product and visit the study site for assessment of desire to smoke
and collection of samples for the evaluation of smoking-related biomarkers.
effects of study product on a smoker's desire to smoke, measured by changes in scores on
questionnaires given over time. Phase 2 will be a two-week extension, in which subjects will
self-administer the study product and visit the study site for assessment of desire to smoke
and collection of samples for the evaluation of smoking-related biomarkers.
Inclusion Criteria:
- healthy adult smokers
- using at least 1 pack of cigarettes per day, for at least 5 years
Exclusion Criteria:
- allergy to study product components
We found this trial at
1
site
Click here to add this to my saved trials